Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that involves the chronic inflammation of the colon or large intestine. It causes ulcers (sores) and long-lasting inflammation in the digestive tract and typically affects the innermost lining of the colon and rectum. The symptoms of the condition include dehydration, pus or blood in diarrhea, belly pain, fever, and urgent and painful bowel movements. Though the exact cause of the condition has not been identified, abnormal activation of the immune system in an individual’s intestines leads to ulceration portions and chronic inflammation of the colon. Ulcerative colitis can be classified into ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis, or universal colitis and fulminant colitis according to the degree of inflammation and its location. Inflammation in ulcerative proctitis is limited to the rectum. In proctosigmoiditis, inflammation is observed in the sigmoid colon and rectum. Inflammation from the rectum extending to the left colon takes place in left-sided colitis. In universal colitis or pancolitis, inflammation affects the entire colon. Fulminant colitis is a severe but rare form of universal colitis.
Rise in number of patients with ulcerative colitis globally is a prominent factor driving the expansion of the ulcerative colitis treatment market. According to a report published in the Crohn’s & Colitis Foundation of America (CCFA), around 1.6 million people in the U.S were affected with IBD in 2014, with 70,000 new cases reported each year. Of the total number of people with IBD in the U.S, 907,000 had ulcerative colitis. The number of new cases of UC are reportedly rising rapidly in newly industrialized countries in Eastern Europe, South America, Africa, and Asia. Increase in use of antibiotics, westernized dietary patterns, rise in exposure to pollution, and improvement in hygiene are some of the factors playing a pivotal role in the increased incidence of UC in developing countries as compared to developed countries. The highest increase in the incidence of these conditions has been reported in countries such as Japan, India, China, etc..
New collaborations and partnerships between biopharmaceutical companies is also helping in providing novel treatment options for the management of UC. In February 2018, Cook Biotech Inc. entered into a new partnership with Regentys in order to develop a new treatment for UC. As per the agreement, Cook Biotech will develop and produce Regentys ECMH Rectal Solution (extracellular matrix hydrogel), a patented and non-surgical hydrogel therapy for patients suffering from ulcerative colitis. In December 2017, Roche announced a collaborative agreement with Boehringer Ingelheim for the discovery and manufacture of novel LNA (locked nucleic acid) oligonucleotides used in the management of inflammatory bowel diseases such as UC.
The global ulcerative colitis treatment market can be segmented based on treatment, end-user, and geography. In terms of treatment, the ulcerative colitis treatment market can be divided into
non-surgical and surgical. The non-surgical segment can be further classified into 5-aminosalicylic acid, corticosteroids, immunosuppressants, and others. Based on end-user, the ulcerative colitis treatment market can be divided into hospitals, ambulatory surgical centers, and clinics.
In terms of geography, the global ulcerative colitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global ulcerative colitis treatment market due to a sizeable population with UC along with continued funding for development of new therapeutics for the treatment of the condition. North America is followed by Europe. Infusion of fresh capital by private investment firms in companies involved in the research of innovative treatment methods for UC is likely to propel the ulcerative colitis treatment market in Europe. In May 2018, Sublimity Therapeutics Limited, a specialty pharmaceutical company, announced that it had successfully raised US$ 64 Mn from investment firms led by Longitude Capital, OrbiMed, and HBM Healthcare Investments. The proceeds from the capital raised will be used for the clinical development of STI-0529 for the treatment of moderate to severe UC.
Prominent players operating in the global ulcerative colitis treatment market are Boehringer Ingelheim, Cook Biotech Inc., Pfizer, Inc, Regentys, and Sublimity Therapeutics Limited.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.